Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000504468 | SCV000596636 | uncertain significance | not specified | 2016-09-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000536830 | SCV000655466 | likely benign | PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314875 | SCV000847715 | likely benign | Inborn genetic diseases | 2017-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001653862 | SCV001862629 | benign | not provided | 2019-04-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001653862 | SCV004164253 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | PURA: BS1 |
Prevention |
RCV003979898 | SCV004792383 | likely benign | PURA-related condition | 2021-07-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |